ICYMI: THE COST OF BIG PHARMA’S EGREGIOUS PATENT ABUSE ON BRAND NAME INHALERS
Physicians Highlight How Big Pharma Games the System to Boost Profits and Block Competition from More Affordable Alternatives On Thursday, an op-ed in The Washington Post from William B. Feldman and Aaron S. Kesselheim, physicians at Brigham and Women’s Hospital and faculty members at Harvard Medical School, highlighted Big Pharma’s extensive patent abuse on brand